Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Myricx Pharma Ltd. (Myricx Bio)
Headquarters: London, United Kingdom
Website: https://myricxpharma.com/
Year Founded: 2019
Status: Private
BioCentury | Jul 12, 2024
Finance
Venture Report: With more company creation on tap, Flagship raises $3.6B
Plus: Big rounds for Element, Beacon and Myricx
BioCentury | May 14, 2024
Data Byte
The diverse modalities targeting B7-H3
ADCs against the target have raised safety concerns, but companies are hitting B7-H3 with other modalities
BioCentury | Dec 23, 2023
Discovery & Translation
Taking next-gen mAbs to new heights will lead modality innovation
Execs and investors weigh in on which technologies will yield the biggest gains in innovation in the near term and beyond: BioCentury survey
BioCentury | Dec 13, 2023
Emerging Company Profile
Myricx: ADCs with a lipidation inhibitor payload
U.K.-based Myricx is turning a small molecule for parasitic diseases into an ADC payload for cancers
BioCentury | Nov 15, 2023
Management Tracks
Rivus appoints Smith as chair and hires Schott as CMO
Plus: Noema and K36 hire CMOs and more from Myricx, Outlook and IMIDomics
BioCentury | Oct 5, 2023
Management Tracks
Jonsson to succeed Mason as head of Lilly Diabetes and Obesity
Plus: Grabulovski takes over as CEO of Araris and updates from IGM, Odyssey, Alpine, Nuvig, Rome, Saghmos, Nature’s Toolbox and Myricx
Items per page:
1 - 6 of 6